DIVALERIO v. BEST CARE LABORATORY, LLC

CourtDistrict Court, D. New Jersey
DecidedJanuary 7, 2022
Docket3:20-cv-17268
StatusUnknown

This text of DIVALERIO v. BEST CARE LABORATORY, LLC (DIVALERIO v. BEST CARE LABORATORY, LLC) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DIVALERIO v. BEST CARE LABORATORY, LLC, (D.N.J. 2022).

Opinion

*NOT FOR PUBLICATION*

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY _______________________________________

ERIC DIVALERIO Civil Action No. 20-17268 (FLW) Plaintiff, OPINION v.

BEST CARE LABORATORY, LLC, RAJEEV TALWAR, and TARA PENDERGRAFT,

Defendants.

WOLFSON, Chief Judge:

Plaintiff Eric DiValerio brought this suit against defendants Best Care Laboratory, LLC, (“BCL”), Rajeev Talwar, and Tara Pendergraft (collectively, “Defendants”), alleging breach of three agreements between the parties, namely, the Membership Purchase Agreement (“MPA”), the Marketing and Sales Contractor Agreement (“Independent Contractor Agreement” or “the Agreement”), and a Promissory Note (“Note”), which all relate to Plaintiff’s purchase of BCL ownership shares in exchange for various consideration. Plaintiff also asserts violations of the New Jersey Wage Payment Law (the “Wage Law”), N.J.S.A 34:11-4.1, et seq., and the New Jersey Sales Representatives’ Rights Act (“SRRA”), N.J.S.A. 2A:61A-1, et seq. Defendants brought a Motion to Compel Arbitration, or in the alternative, Motion to Dismiss the Amended Complaint,1 and on October 8, 2021, the Court granted Defendants’ Motion

1 Defendant Talwar only filed a Motion to Compel Arbitration, whereas Defendants BCL and Pendergraft jointly filed a Motion to Compel Arbitration, or in the alternative, Motion to Dismiss the Amended Complaint. ECF Nos. 14, 15. to Compel Arbitration as to Plaintiff’s breach of contract claims, but denied the Motion as to their Wage Law and SRRA claims. DiValerio v. Best Care Laboratory, LLC, No. 20-17268, 2021 WL 4704963 (D.N.J. Oct. 8, 2021). Furthermore, because of an ambiguous venue provision in the Independent Contractor Agreement, the Court requested supplemental briefing regarding whether federal or state court was the proper venue to adjudicate the remaining Wage Law and SRRA

claims. Id. On October 20, 2021, the parties sent a letter to the Court consenting to remain in federal court. ECF No. 25. In light of the parties’ letter, the Court will resolve Defendant BCL and Pendergraft’s joint Motion to Dismiss the Wage Law and SRRA claims. ECF No. 14. For the reasons set forth below, Defendants Motion to Dismiss is GRANTED as to the Wage Law claim (Count IV), and DENIED as to the SRRA claim (Count V). I. FACTUAL BACKGROUND The Court incorporates the facts from its prior Opinion and sets forth only the facts relevant to this Motion to Dismiss. Pursuant to the MPA, Defendants agreed to sell a 40% interest in BCL

to Plaintiff, and in exchange, Plaintiff agreed to, among other things, “direct his book of business exclusively to [BCL],” for which Plaintiff would earn commissions on his sales according to the Independent Contractor Agreement. Am. Compl. ¶¶28, 37; Exs. A, B. According to this Agreement, BCL “engages in the business of providing laboratory services in the field of clinical laboratory services . . . to the medical community, including the physician-office market[,]” and Plaintiff “possesses certain skills and experiences in marketing and selling services such as those provided by [BCL.]” Am. Compl. Ex. B. As such, under this Agreement, BCL agreed to retain Plaintiff “on a non-exclusive basis, as a sales and marketing representative” and that Plaintiff would provide these services2 “as an independent contractor to [BCL], and not as an employee, joint venturer, partner, agent, principal, or otherwise.” Id. Additionally, the Agreement notes that Plaintiff “is not authorized to and shall not act on behalf of [BCL] or bind [BCL] in any manner.” Id. Further, under Exhibit A of the Independent Contractor Agreement, Plaintiff’s compensation for the Services will be solely comprised of a Commission (the “Commission”). Contractor will receive a 25% (the “Commission Rate”) of Net Sales for blood and 50% Commission Rate for toxicology. “Net Sales” means the cash payments actually received by [BCL] with respect to the sale of services to third party customers or clients through [BCL’s] material and direct efforts, less offsets, refunds and credits. No Commission can be earned following the termination of this Agreement by [BCL] for Cause, however, all previously earned but not yet paid commissions shall be payable to the [Plaintiff]. All pricing to customers or clients must be approved in writing by the Company in advance.”

Relevant to the parties’ sales arrangement, under the MPA, Plaintiff represented that he would bring in an average of $300,000 in gross sales per month over the first 12 months. Id. ¶28, 31; Ex. A. If Plaintiff failed to reach this goal, the MPA provided BCL with “the option of refunding the [Plaintiff's] $300,000 loan and Terminating the [MPA].” Id. Ex. A. But, the MPA also stated that

2 The Independent Contractor Agreement presumably contains an error, and omits the exact services Plaintiff is to provide under this Agreement. Section 1 states that:

[BCL] agrees to retain Contractor, on a non-exclusive basis, as a sales and marketing representative for the purpose of providing [BCL] with the following services solely within the Territory set forth in Exhibit A (collectively, the “Services”):

a. comply with and participate in all training and education programs of [BCL], and shall comply with all applicable policies of Company that have been delivered to Contractor;

b. attend meetings with [BCL’s] management team, the time of which shall be mutually agreeable to [Plaintiff] and [BCL].

These terms do not appear to be “services,” but rather, commitments to comply with BCL training policies and attend management meetings. Because Plaintiff’s working relationship with, and the services he provided to, BCL are directly at issue on this Motion, the Court will glean, as best it can, the contours of Plaintiffs’ role and relationship with BCL from the pleadings and agreements. “[n]othing contained herein will affect the commissions earned by the [Plaintiff] pursuant to the Independent Contractor Agreement[.]” Id. II. LEGAL STANDARD A court may grant a motion to dismiss if the complaint fails to state a claim upon which relief can be granted. Fed. R. Civ. P. 12(b)(6). “While a complaint attacked by a Rule 12(b)(6)

motion to dismiss does not need detailed factual allegations, . . . a plaintiff's obligation to provide the grounds of his entitle[ment] to relief requires more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 545 (2007) (quotations and citations omitted); Baraka v. McGreevey, 481 F.3d 187, 195 (3d Cir. 2007) (stating that standard of review for motion to dismiss does not require courts to accept as true “unsupported conclusions and unwarranted inferences” or “legal conclusion[s] couched as factual allegation[s]”) (quotations and citations omitted). Thus, for a complaint to withstand a motion to dismiss under Rule 12(b)(6), the “[f]actual allegations must be enough to raise a right to relief above the speculative level on the assumption that all the allegations in the complaint are

true (even if doubtful in fact) . . . .” Twombly, 550 U.S. at 555 (internal citations omitted). The Supreme Court has emphasized that, when assessing the sufficiency of a civil complaint, a court must distinguish factual contentions and “[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory statements[.]” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
West Penn Allegheny Health System, Inc. v. UPMC
627 F.3d 85 (Third Circuit, 2010)
Karen Malleus v. John George
641 F.3d 560 (Third Circuit, 2011)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Carpet Remnant Warehouse, Inc. v. New Jersey Department of Labor
593 A.2d 1177 (Supreme Court of New Jersey, 1991)
Sam Hargrove v. Sleepy's, LLC (072742)
106 A.3d 449 (Supreme Court of New Jersey, 2015)
Baraka v. McGreevey
481 F.3d 187 (Third Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
DIVALERIO v. BEST CARE LABORATORY, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/divalerio-v-best-care-laboratory-llc-njd-2022.